2 trials evaluate risk of lowering oxygen saturation targets

05/6/2013 | MedPage Today (free registration)

Two studies presented at a pediatric conference reached differing conclusions about the mortality and disability risks of lowering standard oxygen saturation targets for preterm infants. The Canadian Oxygen Trial published in the Journal of the American Medical Association found no significant effect, but the BOOST II study in the New England Journal of Medicine found a higher death rate.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park